advertisement

WGA Rescources

Thein AS 2

Showing records 1 to 2 | Display only abstracts from Thein AS in IGR 22-4

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Thein AS; Hedengran A; Azuara-Blanco A; Arita R; Cvenkel B; Gazzard G; Heegaard S; de Paiva CS; Petrovski G; Prokosch-Willing V; Utheim TP; Virgili G; Kolko M
American Journal of Ophthalmology 2022; 241: 190-197 (IGR: 23-1)


99062 Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?
Mouhammad ZA; Vohra R; Horwitz A; Thein AS; Rovelt J; Cvenkel B; Williams PA; Azuara-Blanco A; Kolko M
Frontiers in neuroscience 2022; 16: 824054 (IGR: 22-4)


Issue 22-4

Change Issue


advertisement

Topcon